Julia Kodysh

2.8k total citations
14 papers, 170 citations indexed

About

Julia Kodysh is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Julia Kodysh has authored 14 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Julia Kodysh's work include Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Julia Kodysh is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Julia Kodysh collaborates with scholars based in United States, Slovenia and United Kingdom. Julia Kodysh's co-authors include Alex Rubinsteyn, Jeff Hammerbacher, Bülent Arman Aksoy, Nina Bhardwaj, Hyunyoung Choi, Sanjiv Kumar, John P. Finnigan, Timothy J. O’Donnell, John C. Castle and Sebastian Boegel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Julia Kodysh

14 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Kodysh United States	5	96	71	48	31	22	14	170
Youjin Lee United States	8	167 1.7×	34 0.5×	96 2.0×	10 0.3×	18 0.8×	18	286
Soma Kobayashi United States	5	47 0.5×	41 0.6×	38 0.8×	24 0.8×	11 0.5×	8	124
Emanuelle M. Rizk United States	7	68 0.7×	69 1.0×	144 3.0×	28 0.9×	19 0.9×	17	217
Sylvia Chien United States	8	50 0.5×	131 1.8×	68 1.4×	36 1.2×	12 0.5×	25	366
Joshua A. Bull United Kingdom	6	33 0.3×	85 1.2×	43 0.9×	10 0.3×	9 0.4×	12	197
Mingshui Chen China	10	114 1.2×	123 1.7×	107 2.2×	8 0.3×	9 0.4×	12	352
Carmen Herling Germany	9	108 1.1×	74 1.0×	59 1.2×	18 0.6×	7 0.3×	23	320
Tze Heng Tan Germany	4	72 0.8×	75 1.1×	134 2.8×	33 1.1×	12 0.5×	6	265
Tobias Hoch Switzerland	2	101 1.1×	90 1.3×	89 1.9×	10 0.3×	8 0.4×	4	200
Cody N. Heiser United States	7	45 0.5×	143 2.0×	60 1.3×	17 0.5×	7 0.3×	13	241

Countries citing papers authored by Julia Kodysh

Since Specialization

Citations

This map shows the geographic impact of Julia Kodysh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kodysh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kodysh more than expected).

Fields of papers citing papers by Julia Kodysh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Kodysh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kodysh. The network helps show where Julia Kodysh may publish in the future.

Co-authorship network of co-authors of Julia Kodysh

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Kodysh. A scholar is included among the top collaborators of Julia Kodysh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Kodysh. Julia Kodysh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Saxena, Mansi, Jonathan F. Anker, Julia Kodysh, et al.. (2025). Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial. Nature Cancer. 6(6). 988–999. 2 indexed citations

Bozkus, Cansu Cimen, Julia Kodysh, Simon K. Cheng, et al.. (2024). CTIM-10. PHASE 1 TRIAL OF PERSONALIZED NEOANTIGEN VACCINES IN COMBINATION WITH STANDARD CARE TO TREAT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii86–viii87. 1 indexed citations

Anker, Jonathan F., Mansi Saxena, Julia Kodysh, et al.. (2024). Atezolizumab plus personalized neoantigen vaccination (PGV001) in patients with urothelial cancer.. Journal of Clinical Oncology. 42(4_suppl). 597–597. 5 indexed citations

Kodysh, Julia, Cansu Cimen Bozkus, Mansi Saxena, et al.. (2021). 334 Phase I study of safety and activity of personalized neoantigen-based vaccines in combination with tumor treating fields for newly diagnosed glioblastoma patients. Regular and Young Investigator Award Abstracts. A360–A360. 2 indexed citations

Kodysh, Julia, Alex Rubinsteyn, Ana-Belén Blázquez, et al.. (2020). CTIM-17. PHASE I STUDY OF THE SAFETY AND IMMUNOGENICITY OF PERSONALIZED NEOANTIGEN VACCINES AND TUMOR TREATING FIELDS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii36–ii36. 4 indexed citations

Kodysh, Julia, Thomas U. Marron, Alex Rubinsteyn, et al.. (2020). Abstract CT173: PGV-001: A phase I trial of a multipeptide personalized neoantigen vaccine in the adjuvant setting. Cancer Research. 80(16_Supplement). CT173–CT173. 1 indexed citations

Boegel, Sebastian, John C. Castle, Julia Kodysh, Timothy J. O’Donnell, & Alex Rubinsteyn. (2019). Bioinformatic methods for cancer neoantigen prediction. Progress in molecular biology and translational science. 164. 25–60. 29 indexed citations

Hormigo, Adı́lia, Alex Rubinsteyn, Julia Kodysh, Ana-Belén Blázquez, & Nina Bhardwaj. (2019). Abstract CT062: A Phase I study of the safety and immunogenicity of personalized mutation-derived tumor vaccine and treatment fields in patients with newly diagnosed glioblastoma. Cancer Research. 79(13_Supplement). CT062–CT062. 1 indexed citations

Blázquez, Ana-Belén, Alex Rubinsteyn, Julia Kodysh, et al.. (2019). A phase I study of the safety and immunogenicity of a multi-peptide personalized genomic vaccine in the adjuvant treatment of solid tumors and hematological malignancies.. Journal of Clinical Oncology. 37(15_suppl). e14307–e14307. 4 indexed citations

10.

Olcina, Monica M., Nikolas G. Balanis, Ryan Kim, et al.. (2018). Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Reports. 25(13). 3721–3732.e6. 26 indexed citations

11.

Rubinsteyn, Alex, Julia Kodysh, Bülent Arman Aksoy, et al.. (2018). Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial. Frontiers in Immunology. 8. 1807–1807. 49 indexed citations

12.

Rubinsteyn, Alex, et al.. (2017). hammerlab/isovar: Version 0.7.0. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

13.

Rubinsteyn, Alex, Tavi Nathanson, Arun Ahuja, et al.. (2017). hammerlab/varcode: Version 0.5.15. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

14.

Kodysh, Julia, et al.. (2011). Google Correlate Whitepaper. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact